The Indian healthcare and pharmaceutical landscape is heading for a marked performance divergence, says Amey Chalke, Pharma Research Analyst at JM Financial. In an interview with ET Now, Chalke said the sector is witnessing strong traction in hospitals and CDMOs, while large generic pharma companies may face earnings pressure from FY27 onwards. Tariff concerns are […]
Shares of Bajaj Finance fell 6.9% to a low of Rs 1,010.25 on the BSE on Tuesday, November 11, even as the company reported a 22% year-on-year (YoY) increase in consolidated net profit for the quarter ended September 30, 2025 (Q2FY26).The sharp decline occurred due to concerns over rising non-performing loans, higher credit costs and […]